| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 01/20/2000 | WO1999049037A3 Protein phosphatase-related molecules |
| 01/20/2000 | WO1999049035A3 Insecticidal compounds from segestria florentina |
| 01/20/2000 | WO1999048927A9 Methods for designing specific ion channel blockers |
| 01/20/2000 | WO1999048916A3 Hypoxia-inducible human genes, proteins, and uses thereof |
| 01/20/2000 | WO1999047674A3 Compounds and methods for therapy and diagnosis of lung cancer |
| 01/20/2000 | WO1999046288A3 A process for isolating and purifying viruses, soluble proteins and peptides from plant sources |
| 01/20/2000 | WO1999040115A9 COMPOSITIONS AND METHODS TO INHIBIT FORMATION OF THE C5b-9 COMPLEX OF COMPLEMENT |
| 01/20/2000 | WO1999026966A3 Nuclear receptor ligands and ligand binding domains |
| 01/20/2000 | DE19932908A1 Bacillus genes for synthesis of anticapsin and bacilysine are useful as antagonists of glucosamine synthesis |
| 01/20/2000 | DE19921676A1 Aminosäuresequenz Amino acid sequence |
| 01/20/2000 | DE19831312A1 Transgenic mice useful for controlled in vivo cell ablation through recombinase activated expression of cell death inducible genes |
| 01/20/2000 | CA2339355A1 Anthrax vaccine |
| 01/20/2000 | CA2337966A1 Vaccine against staphylococcus intoxication |
| 01/20/2000 | CA2337685A1 Modified proteins |
| 01/20/2000 | CA2337438A1 Novel inhibitors of angiogenesis and tumor growth |
| 01/20/2000 | CA2337258A1 2-aminopyridine derivatives, their use as medicines and pharmaceutical compositions containing them |
| 01/20/2000 | CA2337101A1 Papillomavirus cellular receptor |
| 01/20/2000 | CA2336710A1 Protein secretion from bacteria having reduced expression of a product encoded by the dlt operon |
| 01/20/2000 | CA2336587A1 Botulinum neurotoxin vaccine |
| 01/20/2000 | CA2335272A1 Mouse growth hormone secretagogue receptor |
| 01/20/2000 | CA2334160A1 Method for producing a peptide with a pi above 8 or below 5 |
| 01/20/2000 | CA2334079A1 Genes for the biosynthesis of anticapsin and bacilysine, their isolation and their use |
| 01/20/2000 | CA2334043A1 Antibiotic protein and method of production |
| 01/20/2000 | CA2333928A1 Compounds and methods for modulating cadherin-mediated functions |
| 01/20/2000 | CA2333898A1 Chemotaxis-inhibiting protein of staphylococcus (chips) and its use |
| 01/20/2000 | CA2333893A1 Delta cleavage products and methods based thereon |
| 01/20/2000 | CA2333891A1 Conditional mutants of influenza virus m2 protein |
| 01/20/2000 | CA2333857A1 Growth hormone secretagogue related receptors and nucleic acids |
| 01/20/2000 | CA2333855A1 Isolated amphiphilic peptides derived from the cytoplasmic tail of viral envelope proteins |
| 01/20/2000 | CA2333308A1 Enhancer elements for increased translation in plant plastids |
| 01/20/2000 | CA2333148A1 Expression of eukaryotic peptides in plant plastids |
| 01/20/2000 | CA2332625A1 Interaction of human beta amyloid precursor protein (.beta.-app) with human lon-protease like protein (hslon) |
| 01/20/2000 | CA2332568A1 Tumor antigen peptide originating in sart-1 |
| 01/20/2000 | CA2332346A1 Usurpin, a mammalian ded-caspase homologue that precludes caspase-8 recruitment and activation by the cd-95 (fas, apo-1) receptor complex |
| 01/20/2000 | CA2332344A1 Method for identifying a presenilinase inhibitor |
| 01/20/2000 | CA2332307A1 Human transport protein homologs |
| 01/19/2000 | EP0972840A2 New attenuated myxoma recombinant virus and its use in the preparation of mixed vaccines against myxomatosis and rabbit hemorrhagic disease |
| 01/19/2000 | EP0972839A1 Insertional mutations in mycobacteria |
| 01/19/2000 | EP0972838A1 Escherichia coli host/vector system based on antibiotic-free selection by complementation of an auxotrophy |
| 01/19/2000 | EP0972837A2 Ubiquitin specific protease like protein |
| 01/19/2000 | EP0972834A1 Induction promoter gene and secretory signal gene usable in schizosaccharomyces pombe, expression vectors having the same, and use thereof |
| 01/19/2000 | EP0972832A1 New gene with reduced expression in metastatic human melanoma cells and the protein coded thereby, methods of production and use thereof |
| 01/19/2000 | EP0972831A1 Antisense oligonucleotides against the alpha regulatory subunit of the cAMP dependent-protein kinase for treatment of cancer |
| 01/19/2000 | EP0972830A1 Cancer-associated genes |
| 01/19/2000 | EP0972781A1 Proteins polypeptides and uses thereof |
| 01/19/2000 | EP0972780A1 Il-6 antagonist peptides |
| 01/19/2000 | EP0972779A2 Oligonucleotide-polyamide conjugates |
| 01/19/2000 | EP0972564A2 Combinatorial strategies for polymer synthesis |
| 01/19/2000 | EP0972523A2 Method and compositions for inducing immunity to viruses |
| 01/19/2000 | EP0972200A1 Screening and treatment using complement regulator or receptor proteins |
| 01/19/2000 | EP0972197A1 Method for identifying inhibitors of jak2/cytokine receptor binding |
| 01/19/2000 | EP0972067A1 Method for reversible immobilizing oligo- and/or polysaccharides |
| 01/19/2000 | EP0972064A1 Methods for producing retroviral vectors with an altered tropism |
| 01/19/2000 | EP0972063A2 Adenovirus vectors specific for cells expressing alpha-fetoprotein and methods of use thereof |
| 01/19/2000 | EP0972062A2 Plant pest control |
| 01/19/2000 | EP0972060A1 Method and means for modulating plant cell cycle proteins and their use in plant cell growth control |
| 01/19/2000 | EP0972058A1 Method of hybrid seed production using conditional female sterility |
| 01/19/2000 | EP0972056A1 Reagents and methods useful for detecting diseases of the lung |
| 01/19/2000 | EP0972055A1 Method for producing purified and optionally marked tsh receptor preparations, radioiodized tsh receptor preparations and the use of preparations of this type in diagnostics and therapy |
| 01/19/2000 | EP0972054A1 Enhancement of immune response using targeting molecules |
| 01/19/2000 | EP0972050A1 Csk homologons kinaze (chk) for detecting and treating breast cancer |
| 01/19/2000 | EP0972048A1 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 01/19/2000 | EP0972047A2 Papilloma virus main capsid protein and the use thereof in diagnosis, therapy and vaccination |
| 01/19/2000 | EP0972046A1 METHODS OF PRODUCING AND USING VIRULENCE ATTENUATED $i(poxR) MUTANT BACTERIA |
| 01/19/2000 | EP0972045A1 NUCLEIC ACID FRAGMENTS AND POLYPEPTIDE FRAGMENTS DERIVED FROM $i(M. TUBERCULOSIS) |
| 01/19/2000 | EP0972044A1 Chemokine beta-6 |
| 01/19/2000 | EP0972043A1 Human rantes mutants incapable of aggregate formation |
| 01/19/2000 | EP0972042A1 Polypeptide expressed in the horny layer of epidermis and use thereof |
| 01/19/2000 | EP0972041A1 Novel human delta3 compositions and therapeutic and diagnostic uses therefor |
| 01/19/2000 | EP0972040A1 Human gtp binding protein |
| 01/19/2000 | EP0972039A1 Universal stem cells |
| 01/19/2000 | EP0972038A1 Human tumorigenesis associated protein, htap |
| 01/19/2000 | EP0972037A2 $g(b)-CATENIN, TCF-4, AND APC INTERACT TO PREVENT CANCER |
| 01/19/2000 | EP0972036A2 Prion propagation inhibition by dominant-negative prion protein mutants |
| 01/19/2000 | EP0972035A1 Human tumor suppressor |
| 01/19/2000 | EP0972034A1 Bi- or multifunctional molecules based on a dendroaspin scaffold |
| 01/19/2000 | EP0972033A1 Modulators of the function of receptors of the tnf/ngf receptor family |
| 01/19/2000 | EP0972032A2 Peptides for the treatment of systemic lupus erythematosus |
| 01/19/2000 | EP0972031A1 Procollagen assembly |
| 01/19/2000 | EP0972030A2 70human secreted proteins |
| 01/19/2000 | EP0972029A1 Human secreted proteins |
| 01/19/2000 | EP0972028A1 Vascular endothelial growth factor c (vegf-c) protein and gene, mutants thereof, and uses thereof |
| 01/19/2000 | EP0972027A1 Human c5a-like receptor |
| 01/19/2000 | EP0972026A2 Secreted proteins and polynucleotides encoding them |
| 01/19/2000 | EP0972025A1 I-flice, a novel inhibitor of tumor necrosis factor receptor-1 and cd-95 induced apoptosis |
| 01/19/2000 | EP0972024A1 A tumor suppressor designated ts10q23.3 |
| 01/19/2000 | EP0972023A2 Fc RECEPTORS AND POLYPEPTIDES |
| 01/19/2000 | EP0972022A2 Polynucleotides and polypeptides encoding receptors |
| 01/19/2000 | EP0972021A1 Extracellular/epidermal growth factor like protein |
| 01/19/2000 | EP0972020A1 Insulin-like growth factor agonist peptides |
| 01/19/2000 | EP0972018A1 Non human transgenic animal in which the expression of the gene coding for insulin is deleted |
| 01/19/2000 | EP0972013A1 Tissue specific promoters |
| 01/19/2000 | EP0971958A1 Method for purifying factor viii/vwf complex by cation-exchange chromatography |
| 01/19/2000 | EP0971957A1 Polypeptide with appetite regulating activity |
| 01/19/2000 | EP0971956A2 Synthetic saposin c-derived neurotrophic peptides |
| 01/19/2000 | EP0971955A1 Secreted proteins |
| 01/19/2000 | EP0971954A2 Secreted proteins and polynucleotides encoding them |
| 01/19/2000 | EP0971953A1 Vp22 proteins and uses thereof |
| 01/19/2000 | EP0971952A2 Diagnosis method and reagents |
| 01/19/2000 | EP0971951A1 Diagnosis of colorectal cancer and proteins and antibodies for use therein |